MacroGenics
MGNX
#9393
Rank
โ‚น7.78 B
Marketcap
โ‚น123.08
Share price
-0.72%
Change (1 day)
-57.13%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น24.32 Billion

According to MacroGenics's latest financial reports the company's total assets are โ‚น24.32 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น22.44 B-9.65%
2023-12-31โ‚น24.84 B7.04%
2022-12-31โ‚น23.20 B-6.99%
2021-12-31โ‚น24.95 B-9.91%
2020-12-31โ‚น27.69 B24.3%
2019-12-31โ‚น22.28 B-4.04%
2018-12-31โ‚น23.22 B-2.72%
2017-12-31โ‚น23.87 B12.86%
2016-12-31โ‚น21.15 B-11.41%
2015-12-31โ‚น23.87 B116.64%
2014-12-31โ‚น11.02 B41.82%
2013-12-31โ‚น7.77 B164.06%
2012-12-31โ‚น2.94 B-11.25%
2011-12-31โ‚น3.31 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Xencor
XNCR
โ‚น78.05 B 220.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น18.751 T 76,989.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น11.637 T 47,744.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น5.258 T 21,517.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น8.097 T 33,191.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น10.325 T 42,348.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.704 T 35,683.69%๐Ÿ‡บ๐Ÿ‡ธ USA